by Matthew Perrone This image provided by Biogen on Monday, June 7, 2021, shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer’s drug that is likely to limit the use of the expensive therapy, which has faced an intense public...
